180 Life Sciences Corp. (ATNF) Financials

ATNF Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 5.0 million 5.1 million
2023-06-30 13.7 million 7.0 million
2023-03-31 14.9 million 7.8 million
2022-12-31 19.7 million 8.3 million

ATNF Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.8 million 583994
2023-06-30 -3.1 million 551310
2023-03-31 -3.9 million 557421
2022-12-31 -2.9 million 630846

ATNF Net Income

No data available :(

ATNF Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 2.7 million - -
2023-06-30 2.0 million - -
2023-03-31 2.6 million - -
2022-12-31 7.0 million - -

ATNF Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 8.0 million
2023-06-30 5.2 million
2023-03-31 3.7 million
2022-12-31 2.2 million

ATNF Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.1 million 2.4 million -
2023-06-30 - 920904 2.8 million -
2023-03-31 - 794993 4.0 million -
2022-12-31 - 585690 5.1 million -

ATNF Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 32693
2023-06-30 - 28550
2023-03-31 - 21772
2022-12-31 - 37608

ATNF

Price: $2

52 week price:
1.48
27.93

Earnings Per Share: -269.80 USD

P/E Ratio: -0.01

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 344800

Market Capitalization: 1.6 million

Links: